A Randomised, Double-Blind, Double-Dummy, Active and Placebo Controlled Phase 1 Study of the Safety, Tolerability and Immunogenicity of the Codavax Influenza Vaccine in healthy volunteers

Trial Profile

A Randomised, Double-Blind, Double-Dummy, Active and Placebo Controlled Phase 1 Study of the Safety, Tolerability and Immunogenicity of the Codavax Influenza Vaccine in healthy volunteers

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 04 May 2017

At a glance

  • Drugs Influenza A virus H1N1 vaccine Codagenix (Primary) ; Influenza virus vaccine
  • Indications Influenza virus infections
  • Focus Adverse reactions; First in man
  • Sponsors Codagenix
  • Most Recent Events

    • 04 May 2017 Status changed from recruiting to active, no longer recruiting.
    • 10 Mar 2017 Status changed from not yet recruiting to recruiting.
    • 21 Feb 2017 Status changed from planning to not yet recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top